Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -52.8M | -47% | $ 112.34M |
3/31/2025 | $ -20.48M | -21.09% | $ 97.12M |
12/31/2024 | $ 13.55M | 15.2% | $ 89.15M |
9/30/2024 | $ -45.86M | -1785.86% | $ 2.57M |
6/30/2024 | $ -44.16M | -8831.4% | $ 500K |
3/31/2024 | $ -53.55M | -535470% | $ 10K |
12/31/2023 | $ -59.27M | -197553.33% | $ 30K |
9/30/2023 | $ -30.46M | -2263.3% | $ 1.35M |
6/30/2023 | $ -34.28M | -2546.88% | $ 1.35M |
3/31/2023 | $ -32.76M | -2452.4% | $ 1.34M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ARS PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -18.9M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |